Sijie Lu

1.7k total citations · 1 hit paper
25 papers, 1.3k citations indexed

About

Sijie Lu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Sijie Lu has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Sijie Lu's work include Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (7 papers) and Acute Myeloid Leukemia Research (5 papers). Sijie Lu is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (7 papers) and Acute Myeloid Leukemia Research (5 papers). Sijie Lu collaborates with scholars based in United States, China and Japan. Sijie Lu's co-authors include Tomohide Yamazaki, Pawel Muranski, Xuexian O. Yang, Natalia Martín‐Orozco, Patrick Hwu, Nicholas P. Restifo, Yeonseok Chung, Willem W. Overwijk, Chen Dong and Jeffrey J. Molldrem and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Immunity.

In The Last Decade

Sijie Lu

20 papers receiving 1.2k citations

Hit Papers

T Helper 17 Cells Promote... 2009 2026 2014 2020 2009 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
    2009 618 citations Natalia Martín‐Orozco, Pawel Muranski et al. Immunity profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Sijie Lu 904 688 254 172 97 25 1.3k
Mobin Karimi 524 0.6× 414 0.6× 291 1.1× 198 1.2× 71 0.7× 32 927
Robert Berahovich 778 0.9× 794 1.2× 311 1.2× 71 0.4× 86 0.9× 29 1.3k
Bianca Altvater 736 0.8× 993 1.4× 355 1.4× 147 0.9× 201 2.1× 44 1.4k
I G Schmidt-Wolf 636 0.7× 653 0.9× 190 0.7× 96 0.6× 83 0.9× 24 1.0k
Mingqing Zhu 380 0.4× 439 0.6× 246 1.0× 278 1.6× 101 1.0× 53 809
Antonia Busse 461 0.5× 567 0.8× 495 1.9× 180 1.0× 49 0.5× 54 1.1k
Weiqing Jing 479 0.5× 452 0.7× 225 0.9× 248 1.4× 63 0.6× 29 825
Anna Morabito 559 0.6× 447 0.6× 223 0.9× 77 0.4× 83 0.9× 37 992
Rogier M. Reijmers 577 0.6× 325 0.5× 438 1.7× 194 1.1× 100 1.0× 33 1.1k
Erik Ames 740 0.8× 488 0.7× 178 0.7× 160 0.9× 38 0.4× 26 965

Countries citing papers authored by Sijie Lu

Since Specialization
Citations

This map shows the geographic impact of Sijie Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sijie Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sijie Lu more than expected).

Fields of papers citing papers by Sijie Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sijie Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sijie Lu. The network helps show where Sijie Lu may publish in the future.

Co-authorship network of co-authors of Sijie Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Sijie Lu. A scholar is included among the top collaborators of Sijie Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sijie Lu. Sijie Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lu, Sijie, Jian Li, Mingming Li, et al.. (2025). Extracorporeal membrane oxygenation in pregnancy and the post-partum period: a systematic review and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine. 38(1). 2457002–2457002. 2 indexed citations
3.
4.
Lu, Sijie, Qiaochuan Li, Lisa S. St. John, et al.. (2024). Hu8F4-CAR T cells with mutated Fc spacer segment improve target specificity and mediate anti-leukemia activity in vivo. Cytotherapy. 26(11). 1331–1340. 1 indexed citations
5.
Lu, Sijie, Xiaoling Ding, Dan Li, et al.. (2021). Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemia. Cytotherapy. 23(9). 793–798. 1 indexed citations
6.
He, Hong, Yukio Kondo, Ken Ishiyama, et al.. (2020). Two unique HLA-A*0201 restricted peptides derived from cyclin E as immunotherapeutic targets in leukemia. Leukemia. 34(6). 1626–1636. 9 indexed citations
7.
Im, Jin S., Sumedha Pareek, Sijie Lu, et al.. (2019). A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2. Frontiers in Immunology. 9. 3153–3153. 13 indexed citations
8.
9.
10.
Zhang, Mao, Pariya Sukhumalchandra, Lisa S. St. John, et al.. (2012). A Novel HLA-A*0201 Restricted Peptide Derived from Cathepsin G Is an Effective Immunotherapeutic Target in Acute Myeloid Leukemia. Clinical Cancer Research. 19(1). 247–257. 19 indexed citations
11.
Mittendorf, Elizabeth A., Gheath Alatrash, Na Qiao, et al.. (2012). Breast Cancer Cell Uptake of the Inflammatory Mediator Neutrophil Elastase Triggers an Anticancer Adaptive Immune Response. Cancer Research. 72(13). 3153–3162. 72 indexed citations
12.
Alatrash, Gheath, Yoko Ono, Анна Сергеева, et al.. (2012). The Role of Antigen Cross-presentation From Leukemia Blasts on Immunity to the Leukemia-associated Antigen PR1. Journal of Immunotherapy. 35(4). 309–320. 19 indexed citations
13.
Armistead, Paul M., Shoudan Liang, Hua Li, et al.. (2011). Common Minor Histocompatibility Antigen Discovery Based upon Patient Clinical Outcomes and Genomic Data. PLoS ONE. 6(8). e23217–e23217. 18 indexed citations
14.
Сергеева, Анна, Gheath Alatrash, Hong He, et al.. (2011). An anti–PR1/HLA-A2 T-cell receptor–like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells. Blood. 117(16). 4262–4272. 91 indexed citations
15.
Kanodia, Shreya, Eric Wieder, Sijie Lu, et al.. (2010). PR1-Specific T Cells Are Associated with Unmaintained Cytogenetic Remission of Chronic Myelogenous Leukemia After Interferon Withdrawal. PLoS ONE. 5(7). e11770–e11770. 24 indexed citations
16.
Ma, Qing, Changqing Wang, Dan Jones, et al.. (2010). Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model. Cytotherapy. 12(8). 1056–1062. 27 indexed citations
17.
Martín‐Orozco, Natalia, Pawel Muranski, Yeonseok Chung, et al.. (2009). T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity. Immunity. 31(5). 787–798. 618 indexed citations breakdown →
18.
Qazilbash, Muzaffar H., Eric Wieder, Peter F. Thall, et al.. (2007). PR1 Vaccine Elicited Immunological Response after Hematopoietic Stem Cell Transplantation Is Associated with Better Clinical Response and Event-Free Survival.. Blood. 110(11). 577–577. 19 indexed citations
19.
Qazilbash, Muzaffar H., Eric Wieder, Peter F. Thall, et al.. (2007). PR1 Peptide Vaccine-Induced Immune Response Is Associated with Better Event-Free Survival in Patients with Myeloid Leukemia.. Blood. 110(11). 283–283. 27 indexed citations
20.
Molldrem, Jeffrey J., Peter P. Lee, Shreya Kant, et al.. (2003). Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells. Journal of Clinical Investigation. 111(5). 639–647. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mobin Karimi Breakdown of academic impact, for papers by Robert Berahovich Breakdown of academic impact, for papers by Bianca Altvater Breakdown of academic impact, for papers by I G Schmidt-Wolf Breakdown of academic impact, for papers by Mingqing Zhu Breakdown of academic impact, for papers by Antonia Busse Breakdown of academic impact, for papers by Weiqing Jing Breakdown of academic impact, for papers by Anna Morabito Breakdown of academic impact, for papers by Rogier M. Reijmers Breakdown of academic impact, for papers by Erik Ames
Rankless by CCL
2026